Pfizer exec moves to Merck KGaA to head fertility in USA

Cheryl Schwartz has brought her time with drug giant Pfizer (NYSE: PFE) to an end by becoming a vice president with German drugmaker Merck KGaA (MRK: DE), where she will head up US fertility and endocrinology.

Ms Schwartz has been with Pfizer since 2004 and was most recently general manager of its US biosimilars business. Her previous roles with the company have included leading the global commercialization of Prevnar 13.

Germany’s Merck, which in the USA goes by the name EMD Serono, is one of the world’s leading companies in the fertility space.